Randomized, multicenter comparison of oral granisetron and oral ondansetron for emetogenic chemotherapy

Pharmacotherapy

Volumn 20, Issue 11, 2000, Pages 1318-1323

  Herrington, Jon D ^a   Kwan, Peter ^d   Young, Robyn R ^b   Lagow, Elaine ^a   Lagrone, Lore ^a   Riggs, Mark W ^c  

^a Department of Pharmacy Medicine ^*  (United States)

^b Division of Hematology/Oncology   (United States)

^c Scott White Mem Hosp and Clinics   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DACARBAZINE; DAUNORUBICIN; DEXAMETHASONE; DOXORUBICIN; GRANISETRON; IDARUBICIN; IFOSFAMIDE; METHOTREXATE; MITOXANTRONE; ONDANSETRON;

ADULT; AGED; ARTICLE; CANCER; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; FEMALE; FLUSHING; HEADACHE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; RANDOMIZED CONTROLLED TRIAL; VOMITING; XEROSTOMIA;

ADMINISTRATION, ORAL; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; DEXAMETHASONE; DRUG THERAPY, COMBINATION; EMETICS; FEMALE; GRANISETRON; HUMANS; MALE; MIDDLE AGED; NAUSEA; ONDANSETRON;

EID: 0033765216     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.20.17.1318.34894     Document Type: Article

References (19)

1. A double-blind comparison of the efficacy of two dose regimens of oral granisetron in preventing acute emesis in patients receiving moderately emetogenic chemotherapy
2. Comparative clinical trial of granisetron and ondansetron in the prophylaxis of cisplatin-induced emesis
3. Dexamethasone, granistron, or both for the prevention of nausea and vomiting during chemotherapy for cancer
4. Oral granisetron alone and in combination with dexamethasone: A double-blind randomized comparison against high-dose metoclopramide plus dexamethasone in prevention of cisplatin-induced emesis
5. Antiemetic treatment with oral granisetron in patients receiving moderately emetogenic chemotherapy: A dose-ranging study
6. Granisetron: An update of its therapeutic use in nausea and vomiting induced by antineoplastic therapy
7. A randomized, double-blind comparison of intravenous ondansetron alone and in corabination with intravenous dexaraethasone in the prevention of high-dose cisplatin-induced emesis
8. Mechanisms by which cancer chemotherapeutic drugs induce emesis
9. A unique all-oral, single-dose, combination antiemetic regimen with high efficacy and marked cost saving potential
10. Comparative efficacy of a single oral dose of ondansetron and of buspirone against cisplatin-induced emesis in cancer patients
11. Stratified, double-blind comparison of intravenous ondansetron administered as a multiple-dose regimen versus two single-dose regimens in the prevention of cisplatin-induced nausea and vomiting
12. Comparison of the antiemetic efficacy of different doses of ondansetron, given as either a continuous infusion or a single intravenous dose, in acute cisplatin-induced emesis. A multicentre, double-blind, randomized, parallel group study
13. Double-blind, dose-finding study of four intravenous doses of dexamethasone in the prevention of cisplatin-induced acute emesis
14. Proposal for classifying the acute emetogenicity of cancer chemotherapy
15. Recommendations for the use of antiemetics: Evidence-based, clinical practice guidelines
16. ASHP therapeutic guidelines on the pharmacologic management of nausea and vomiting in adult and pediatric patients receiving chemotherapy or radiation therapy or undergoing surgery
17. NCCN antiemesis practice guidelines
18. Determinants of post-chemotherapy nausea and vomiting in patients with cancer